Comparison of 24-month treatment outcomes between as-needed treatment and switching to treat-and-extend in type 3 macular neovascularization
Abstract This study aimed to compare 24-month treatment outcomes between patients with type 3 macular neovascularization (MNV) treated using an as-needed regimen and those who switched to treat-and-extend (TAE). This retrospective study included 32 patients who were initially treated with an as-need...
Main Authors: | Jae Hui Kim, Jong Woo Kim, Chul Gu Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-12-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-25860-5 |
Similar Items
-
Investigation of the Trend of Selecting Anti-Vascular Endothelial Growth Factor Agents for the Initial Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
by: Jae-Hui Kim, et al.
Published: (2021-08-01) -
Neovascular age-related macular degeneration without exudative recurrence over 24 months after initial remission
by: Han Joo Cho, et al.
Published: (2022-09-01) -
Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy
by: Yongseok Mun, et al.
Published: (2022-09-01) -
Prediction of anti-vascular endothelial growth factor agent-specific treatment outcomes in neovascular age-related macular degeneration using a generative adversarial network
by: Sehwan Moon, et al.
Published: (2023-04-01) -
Two-year outcomes of treat-and-extend regimen with intravitreal brolucizumab for treatment-naïve neovascular age-related macular degeneration with type 1 macular neovascularization
by: Hidetaka Matsumoto, et al.
Published: (2023-02-01)